SCHEMBL29494447

SCHEMBL29494447

Cc1ccc(NC(N)=O)cc1C(=O)NCc1cnc2ccccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ NPC1 O15118 4/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ GAA P10253 1/20 0.50
▸ KCNH2 Q12809 1/20 0.42
▸ KCNB1 Q14721 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDR P35968 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ABCB1 P08183 1/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.39
▸ BRAF P15056 1/20 0.39
▸ BTK Q06187 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494530 0.90 NPC1 (0.51) MAPTNPC1RAB9AGAAKCNH2
SCHEMBL29494547 0.90 RAB9A (0.48) MAPTNPC1RAB9AGAAKCNH2
SCHEMBL29494565 0.86 KCNB1 (0.46) MAPTNPC1RAB9AGAAKCNH2
SCHEMBL29494552 0.86 ADORA2A (0.43) MAPTNPC1RAB9AKCNH2KCNB1
SCHEMBL29494507 0.76 BLK (0.52) MAPTKCNH2KCNB1KDM4EALDH1A1
SCHEMBL29494503 0.76 HDAC1 (0.44) NPC1RAB9AKDM4EALDH1A1HTT
SCHEMBL29494485 0.73 KCNH2 (0.45) MAPTNPC1RAB9AKCNH2KCNB1
SCHEMBL9365921 0.71 KDM4E (0.51) NPC1RAB9AGAAKDM4ELMNA
SCHEMBL29494496 0.70 MAPT (0.50) MAPTNPC1RAB9AGAAKDM4E
SCHEMBL29494535 0.70 KLKB1 (0.49) MAPTNPC1RAB9AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback